Latest Partnerships News

Global Uranium and Enrichment Limited’s investee Ubaryon has sealed a binding agreement with uranium giant Urenco, unlocking a A$5 million investment and technical collaboration to accelerate a novel uranium enrichment technology.

Brazilian Rare Earths Limited (BRE) confirms Sulista West as an ultra high-grade rare earth project with exceptional drill results and reports metallurgical breakthroughs at Monte Alto, underpinning its integrated supply chain ambitions.

Bannerman Energy reported a robust $80 million cash inflow from financing in Q2 2025, offsetting significant exploration expenditures and maintaining a strong cash position.

Avecho Biotechnology reports strong progress in its Phase III clinical trial for a CBD-based insomnia treatment, with recruitment accelerating across multiple Australian sites and interim results expected early next year.

Urbanise.com Limited reported a 4.2% revenue increase for FY2025, driven by a landmark partnership and equity investment from National Australia Bank. The company achieved positive operating cash flow for the fourth consecutive quarter, setting the stage for its next growth phase.

AusQuest Limited has reported significant new coarse-grained magnetite intersections across multiple prospects at its Morrisey Project in Western Australia, signaling promising potential for premium iron product development.

Geopacific Resources has launched a major drilling campaign at its Woodlark Gold Project, unveiling high-grade surface results and new exploration targets, while St Barbara Limited moves to become a strategic shareholder.

TALi Digital has acquired the You Can Do It! education program, boosting its social-emotional learning portfolio, while raising $0.8 million through a private placement to support growth initiatives.

Osteopore Limited reports a three-fold increase in craniofacial implant sales within a year of signing an exclusive distribution deal with Zimmer Biomet, signaling strong early traction across key global markets.

Spacetalk Ltd reports robust growth in paid mobile subscribers and recurring revenue for Q4 FY25, supported by strategic capital raises and international expansion.

Nova Eye Medical has reported a record A$29.2 million revenue for FY25, driven by strong sales growth and improved profitability in its glaucoma segment. The company targets breakeven EBITDA in the first half of FY26 amid promising regulatory and market developments.

Algorae Pharmaceuticals has advanced its AI-driven drug discovery platform into preclinical validation through a strategic collaboration with the Peter MacCallum Cancer Centre, while progressing its therapeutic pipeline and commercial leadership.